Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-26 @ 1:19 PM
NCT ID:
NCT04722406
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed aNSCLC patients
* Having received anti-PD-1/PD-L1 therapy
* Must have two consecutive computed tomography (CT) scans upon early treatment (from baseline to the first imaging evaluation)
Exclusion Criteria:
* Lacking available computed tomography (CT) evaluation at any of two time points-baseline and the first evaluation
* Without measurable lesions at baseline CT scan
* Having received local anticancer therapy during ICI treatment, for example, radiotherapy and radiofrequency ablation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04722406
Study Brief:
Protocol Section:
NCT04722406